Lv2
120 积分 2022-02-21 加入
Circulating tumor DNA as a biomarker in early phase clinical trials
1个月前
已完结
ESR1 mutations: a new biomarker in breast cancer
7个月前
已完结
PADA-1 trial: ESR1 mutations in plasma ctDNA guide treatment switching
7个月前
已完结
Practical Considerations for the Use of Circulating Tumor DNA in the Treatment of Patients With Cancer: A Narrative Review
8个月前
已完结